Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001562180-19-005641

Director bought 15,000 shares at $3.52 ($52,800)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Smith Cynthia Director 2019-11-20 Purchase +15,000 $3.52 $52,800 28,700 D: show line 1 in the form
Open-market purchases · 15,000 sh · avg $3.52 · $52,800
Loading xslF345X03/primarydocument.xml…